Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
Metformin, the most widely prescribed drug therapy for type 2 diabetes, has pleiotropic benefits, in addition to its capacity to lower elevated blood glucose levels, including mitigation of cardiovascular risk. The mechanisms underlying the latter remain unclear. Mechanistic studies have, hitherto,...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2020-11-01
|
| シリーズ: | Pharmaceuticals |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/1424-8247/13/11/410 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|